Drug Retention Time of Immunosuppressive Therapy in Behcet's Uveitis
CONCLUSION: Adalimumab's drug retention time was found to be similar to and possibly better than cDMARDs in patients with BU, who often suffer from vision-threatening disease at first presentation.PMID:38412375 | DOI:10.1080/09273948.2024.2315205 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - February 27, 2024 Category: Allergy & Immunology Authors: Donald Tran Sophie Rogers Lyndell L Lim Source Type: research
Long ‐term efficacy, safety, and cumulative retention rate of antitumor necrosis factor‐alpha treatment for patients with Behcet's uveitis: A systematic review and meta‐analysis
ConclusionsAnti-TNF- α therapy represents an effective treatment for BU patients with favorable safety profile and high drug retention rate and a potential advantage of adalimumab over infliximab in terms of ocular inflammation remission, drug retention, and the incidence of severe infusion or injection reactions. (Source: International Journal of Rheumatic Diseases)
Source: International Journal of Rheumatic Diseases - February 25, 2024 Category: Rheumatology Authors: Xin Guan,
Zerui Zhao,
Miaomiao Xin,
Guangtao Xia,
Qingrui Yang,
Min Fu Tags: ORIGINAL ARTICLE Source Type: research
Pseudotumoral neuro-behcet ’s disease: case series and review of literature
ConclusionPT NBD is a rare but life-threatening condition. (Source: Acta Neurologica Belgica)
Source: Acta Neurologica Belgica - February 23, 2024 Category: Neurology Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
HLA-B*51 Frequency in Transplant Patients and Donors
CONCLUSIONS: No significant relationship was shown between patients diagnosed with end-stage renal disease and HLA-B*51 positivity. Previous studies support frequency of the HLA-B*51 allele in the control group. Although Behçet disease is known to cause renal vasculitis, HLA-B*51 positivity alone was not associated with vasculitis or inflammation.PMID:38385410 | DOI:10.6002/ect.MESOT2023.P76 (Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation)
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 22, 2024 Category: Transplant Surgery Authors: Miray Kavuzlu Bircan Zengel Bilkay Ba ştürk Source Type: research
